Literature DB >> 24920949

Influence of environmental exposures on patients with chronic obstructive pulmonary disease in Korea.

Yoonki Hong1, Myoung Nam Lim2, Woo Jin Kim1, Chin Kook Rhee3, Kwang Ha Yoo4, Ji-Hyun Lee5, Ho Il Yoon6, Tae-Hyung Kim7, Jin Hwa Lee8, Seong Yong Lim9, Sang Do Lee10, Yeon-Mok Oh10.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is characterized by airflow limitation and results from environmental factors and genetic factors. Although cigarette smoking is a major risk factor, other environmental exposures can influence COPD. The purpose of this study is to investigate the clinical characteristics of COPD according to the history of environmental exposure.
METHODS: The study population comprised of 347 subjects with COPD who were recruited from the pulmonary clinics of 14 hospitals within the Korean Obstructive Lung Disease Study Group. We classified environmental exposures according to history of living near factory, and direct exposure history to firewood or briquette. According to living environmental exposures, we compared the frequency of respiratory symptoms, pulmonary function, quality of life, exercise capacity, and computed tomography phenotypes.
RESULTS: Thirty-one subjects (8.9%) had history of living near factory, 271 (78.3%) had exposure history to briquette, and 184 (53.3%) had exposure history to firewood. Patients with history of living near a factory had a significantly longer duration of sputum, while patients with exposure to firewood tended to have lower forced expiratory volume in one second, and patients with exposure to briquette tended to have lower six minute walk distance.
CONCLUSION: COPD subjects with the history of living near factory had more frequent respiratory symptoms such as sputum. Our data suggest that environmental exposure may influence clinical phenotype of COPD.

Entities:  

Keywords:  Air Pollutants; Environmental Exposure; Fossil Fuels; Occupational Exposure; Pulmonary Disease, Chronic Obstructive

Year:  2014        PMID: 24920949      PMCID: PMC4050070          DOI: 10.4046/trd.2014.76.5.226

Source DB:  PubMed          Journal:  Tuberc Respir Dis (Seoul)        ISSN: 1738-3536


  11 in total

Review 1.  Global burden of COPD: risk factors, prevalence, and future trends.

Authors:  David M Mannino; A Sonia Buist
Journal:  Lancet       Date:  2007-09-01       Impact factor: 79.321

2.  Chronic obstructive pulmonary disease phenotypes: the future of COPD.

Authors:  MeiLan K Han; Alvar Agusti; Peter M Calverley; Bartolome R Celli; Gerard Criner; Jeffrey L Curtis; Leonardo M Fabbri; Jonathan G Goldin; Paul W Jones; William Macnee; Barry J Make; Klaus F Rabe; Stephen I Rennard; Frank C Sciurba; Edwin K Silverman; Jørgen Vestbo; George R Washko; Emiel F M Wouters; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2010-06-03       Impact factor: 21.405

3.  Lung function decline, chronic bronchitis, and occupational exposures in young adults.

Authors:  Jordi Sunyer; Jan Paul Zock; Hans Kromhout; Raquel Garcia-Esteban; Katja Radon; Deborah Jarvis; Kjell Toren; Nino Künzli; Dan Norbäck; Angelo d'Errico; Isabel Urrutia; Félix Payo; Mario Olivieri; Simona Villani; Marc Van Sprundel; Josep M Antó; Manolis Kogevinas
Journal:  Am J Respir Crit Care Med       Date:  2005-07-22       Impact factor: 21.405

Review 4.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

Authors:  Jørgen Vestbo; Suzanne S Hurd; Alvar G Agustí; Paul W Jones; Claus Vogelmeier; Antonio Anzueto; Peter J Barnes; Leonardo M Fabbri; Fernando J Martinez; Masaharu Nishimura; Robert A Stockley; Don D Sin; Roberto Rodriguez-Roisin
Journal:  Am J Respir Crit Care Med       Date:  2012-08-09       Impact factor: 21.405

5.  Occupational inhalant exposure and respiratory disorders among never-smokers referred to a hospital pulmonary function laboratory.

Authors:  G K Mak; M K Gould; W G Kuschner
Journal:  Am J Med Sci       Date:  2001-09       Impact factor: 2.378

6.  Respiratory symptoms and chronic obstructive pulmonary disease among cement factory workers.

Authors:  Julius Mwaiselage; Magne Bråtveit; Bente E Moen; Yohana Mashalla
Journal:  Scand J Work Environ Health       Date:  2005-08       Impact factor: 5.024

7.  Constrictive bronchiolitis in soldiers returning from Iraq and Afghanistan.

Authors:  Matthew S King; Rosana Eisenberg; John H Newman; James J Tolle; Frank E Harrell; Hui Nian; Mathew Ninan; Eric S Lambright; James R Sheller; Joyce E Johnson; Robert F Miller
Journal:  N Engl J Med       Date:  2011-07-21       Impact factor: 91.245

8.  Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography.

Authors:  Young Kyung Lee; Yeon-Mok Oh; Ji-Hyun Lee; Eun Kyung Kim; Jin Hwa Lee; Namkug Kim; Joon Beom Seo; Sang Do Lee
Journal:  Lung       Date:  2008-03-20       Impact factor: 2.584

Review 9.  Chronic obstructive pulmonary disease in non-smokers.

Authors:  Sundeep S Salvi; Peter J Barnes
Journal:  Lancet       Date:  2009-08-29       Impact factor: 79.321

10.  The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort.

Authors:  Robab Kohansal; Pablo Martinez-Camblor; Alvar Agustí; A Sonia Buist; David M Mannino; Joan B Soriano
Journal:  Am J Respir Crit Care Med       Date:  2009-04-02       Impact factor: 21.405

View more
  2 in total

1.  Comparative analysis of the psychometric parameters of two quality-of-life questionnaires, the SGRQ and CAT, in the assessment of patients with COPD exacerbations during hospitalization: A multicenter study.

Authors:  Ana Folch Ayora; Loreto Macia-Soler; María Isabel Orts-Cortés; Carmen Hernández; Nuria Seijas-Babot
Journal:  Chron Respir Dis       Date:  2018-03-12       Impact factor: 2.444

Review 2.  The current status of chronic obstructive pulmonary disease awareness, treatments, and plans for improvement in South Korea: a narrative review.

Authors:  Yong Bum Park; Kwang Ha Yoo
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 2.895

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.